- Report
- May 2024
- 191 Pages
Global
From €3232EUR$3,374USD£2,752GBP
€3591EUR$3,749USD£3,058GBP
- Report
- May 2024
- 196 Pages
Global
From €5220EUR$5,450USD£4,445GBP
- Report
- December 2023
- 200 Pages
Global
From €4789EUR$5,000USD£4,078GBP
- Report
- October 2023
- 144 Pages
Global
From €2394EUR$2,499USD£2,038GBP
- Report
- August 2023
- 145 Pages
Global
From €3017EUR$3,150USD£2,569GBP
- Report
- January 2024
- 200 Pages
Global
From €3975EUR$4,150USD£3,385GBP
- Report
- July 2023
- 147 Pages
Global
From €2155EUR$2,250USD£1,835GBP
- Report
- May 2024
- 131 Pages
Global
From €6225EUR$6,499USD£5,301GBP
- Report
- May 2024
- 137 Pages
Global
From €6225EUR$6,499USD£5,301GBP
- Report
- May 2024
- 128 Pages
Global
From €6225EUR$6,499USD£5,301GBP
- Report
- May 2024
- 135 Pages
Global
From €6225EUR$6,499USD£5,301GBP
- Report
- February 2024
- 175 Pages
Global
From €3831EUR$4,000USD£3,263GBP
- Report
- May 2023
- 134 Pages
Global
From €2394EUR$2,499USD£2,038GBP
- Report
- October 2023
- 178 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- April 2024
- 180 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- January 2024
- 182 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- August 2023
- 117 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- February 2024
- 115 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- February 2024
- 120 Pages
Global
From €4550EUR$4,750USD£3,874GBP
- Report
- December 2023
- 143 Pages
Global
From €4262EUR$4,450USD£3,630GBP
The Bleeding Disorder market is a subset of the Hematology market, which focuses on the diagnosis, treatment, and prevention of blood-related diseases. Bleeding Disorders are a group of conditions that affect the body's ability to control bleeding. These disorders can be caused by a variety of factors, including genetic mutations, acquired conditions, and environmental factors. Common bleeding disorders include hemophilia, von Willebrand disease, and platelet disorders. Treatment for these disorders typically involves the use of clotting factor concentrates, antifibrinolytic agents, and other medications.
The Bleeding Disorder market is highly competitive, with a number of companies offering products and services to treat these conditions. Some of the major players in the market include Novo Nordisk, Pfizer, Bayer, CSL Behring, and Shire. Show Less Read more